scientific specimen collection, simplified.

our vision & purpose

As the microsampling brand of Trajan Scientific and Medical, we bring you simple, scientifically precise remote specimen collection and microsampling technologies. We are aligned with Trajan’s vision to create and enable science that benefits people and improves wellbeing.

our mission

To innovate and develop quantitative microsampling solutions that are easy to use and amenable to manual and automated analysis in the lab. We simplify sample collection and processing for our scientific and medical customers in pharmaceutical development, clinical research, personalized medicine and related industries, enabling them to make advances that positively impact human health.

our technologies

Our devices facilitate remote specimen collection by anyone, anywhere with ease-of-use, convenience, and simplified logistics for sample transport at reduced costs. Our microsampling technologies ease workflows and enable decentralized research and virtual healthcare models, with a product portfolio that includes the Mitra® device based on VAMS® technology, the hemaPEN®, and additional microsampling products on the way.

the promise of microsampling, delivered.

We use the blood collection kit at home for our son, who is a kidney transplant recipient. The kit has easy instructions, a finger-prick tool & supplies to collect the samples. We use the included shipping envelopes to post samples to our son’s care provider. The kit saves us time and unnecessary trips to the clinic.” 
– Mrs. Lego

Transplant Patient Parent, UK

“One of the greatest advantages we have been able to appreciate about Mitra® with VAMS® technology is the simplicity and rapidity of use, while maintaining high performance and guaranteeing the reliability of quali-quantitative analytical data."
– Laura Mercolini, PhD,

Pharmacy and Biotechnology Research Head, University of Bologna, Italy

"VAMS technology allows convenient at-home monitoring and is minimally invasive. It also offers efficiencies in the clinical setting, as providers will have blood results in hand before meeting with the patient."  
– Dr. Christophe Stove

Ghent University Hospital, Belgium

“For our biomarker analysis by chromatography and mass spectrometry using biological samples, the Mitra® with VAMS® technology has allowed us a rapid and effective tuning and validation process, providing a boost to all the optimization steps. In this way, we were able to concentrate on the stability study with a solid and reliable methodology available."
– Michele Protti, Phd

Pharmacy & Biotechnology Research Scientist, University of Bologna, Italy

“Researchers have considerable experience using these at-home blood collection kits to track the spread of other infectious diseases like influenza, and this method is safe, effective and easy-to-use. With a small finger-pick, volunteers can help scientists fight COVID-19 from their homes.”
– Kaitlyn Sadtler, PhD

Study Lead for Laboratory Testing and Chief, NIH NIBIB’s Section for Immunoengineering, US

“One of the greatest advantages we have been able to appreciate about Mitra® with VAMS® technology is the simplicity and rapidity of use, while maintaining high performance and guaranteeing the reliability of quali-quantitative analytical data."
– Laura Mercolini, PhD

Pharmacy and Biotechnology Research Head, University of Bologna, Italy

our story

Follow our timeline to learn how we developed and grew to where we are today as global leaders in remote specimen collection and microsampling.

2008

A conversation sets VAMS in motion.

Drs. James Rudge and Neil Spooner discuss the limitations of Dried Blood Spot (DBS) cards. This gets James thinking about a dried matrix microsampling tool that will reliably collect fixed-volume samples.

Three rows full of experimental mitra tips
2008
2010-2014

Volumetric absorptive microsampling is born.

Dr. Stuart Kushon and the R&D team at Phenomenex translate James’s idea & prototype for VAMS into a new medical device. Five pharmaceutical companies validate the device, which consistently collects a precise volume of bio-fluid.

Men in white lab coasts, gloves and hair nets assemble Mitra Clamshell Devices
2010-2014
2015

Neoteryx LLC is founded in the US.

Neoteryx is formed as a device company with the goal of commercializing tools based on volumetric absorptive microsampling technology. The company offers Mitra® devices with VAMS® in several formats, including the Mitra 96-Autorack for automated, high-throughput processing of multiple samples.

neoteryx-headquarters-buildings-torrance-ca
2015
2016

Neoteryx launches VAMS technology.

Mitra® devices based on the original, patented VAMS® technology are registered, trademarked and launched under the Neoteryx banner. Research, healthcare and lab professionals start using Mitra devices with VAMS for a range of applications.

mitra-cartridge-remote-specimen-collection-device-1-1-1-1-2
2016
2017-2019

Top organizations adopt Mitra with VAMS.

The NHS, Charles River, Merck and other top science & medicine centers apply Mitra® devices with VAMS® microsampling in pharmaceutical drug discovery & development, clinical research & trials, academic research studies, therapeutic drug monitoring, and public health programs. Hundreds of published studies discuss how VAMS microsampling can be automated for easy workflows and deliver high-quality samples with a 96.8% accuracy rate.

Mitra devices, cartridge, 96-Autorack in Lab
2017-2019
2020 - 2021

A pandemic spurs wider use of microsampling.

The Coronavirus Pandemic boosts adoption of remote microsampling devices and kits for COVID-19 studies by the National Institutes of Health (NIH) and other research centers that allow people to self-sample at home. Virtual clinical trials and remote patient monitoring improve the patient experience. Thousands of Mitra kits are deployed globally, including new Pediatric Collection Kits tailored for researchers seeking a gentler, safer sampling solution for children.

www.neoteryx.comhubfsIONTAS-and-FairJourney-Biologics-discover-COVID-19-neutralizing-antibodies_wrbm_large
2020 - 2021
2022

Neoteryx is acquired by Trajan.

Trajan Scientific and Medical recognizes the promise of microsampling to benefit more people and acquires Neoteryx to expand its microsampling product portfolio. They offer Mitra with VAMS, hemaPEN, and other devices to address a range of needs. Trajan moves closer to realizing its vision of delivering specimen sampling solutions that enable personalized healthcare and preventative medicine for greater global impact.

Trajan Scientific and Medical, Australia-1
2022

What's next...

The microsampling brand of Trajan, Neoteryx supports microsampling across industries around the globe. Our customers choose from multiple microsampling solutions to suit different project needs.

Explore our gold-standard microsampling technologies, industry resources and technical information.

our latest news

Neoteryx Provides Microsampling Devices Onboard the Polaris Dawn Mission
Mitra Microsampling Devices

Neoteryx Provides Microsampling Devices Onboard the Polaris Dawn Mission

November 2,2022 2 min read
Neoteryx provides microsampling devices to fianostics for COVID-19 antibody tests in austria
Mitra devices for COVID-19 Antibody Tests

Neoteryx provides microsampling devices to fianostics for COVID-19 antibody tests in austria

October 31,2022 3 min read
Neoteryx Updates Production, Distribution of Microsampling Solutions
Neoteryx Updates Its Logo

Neoteryx Updates Production, Distribution of Microsampling Solutions

October 20,2022 2 min read
Neoteryx Launches Program to Support Microsampling Studies
Research Support Program

Neoteryx Launches Program to Support Microsampling Studies

September 21,2022 2 min read
Decentralized Clinical Trials Deliver Benefits, Study Shows
Device for Sample Collection at Home

Decentralized Clinical Trials Deliver Benefits, Study Shows

August 18,2022 4 min read
Trajan Licenses Technology to Develop Microbiopsy Device
Microbiopsy Device from Trajan

Trajan Licenses Technology to Develop Microbiopsy Device

April 19,2022 3 min read